Prof. Di Gu | Urology | Best Researcher Award
Deputy Director, First Affiliated Hospital of Guangzhou Medical University, China
Prof. Di Gu, MD, is a distinguished urologist and academic leader, currently serving as Deputy Director of the Department of Urology at the First Affiliated Hospital of Guangzhou Medical University, China. He holds a Doctor of Surgery (Distinction, 2013) from Southern Medical University and a Master of Science (Merit, 2008) in Biomedicine and Molecular Science from King’s College London, alongside a Bachelor of Medicine (Distinction, 2007) from Southern Medical University. His professional experience spans senior clinical and fellowship appointments, including Robotic Clinical Fellow at University College London Hospitals, Senior Clinical Fellow at King’s College Hospital and Urology Fellow at Nanfang Hospital, Southern Medical University. Prof. Di Gu’s research interests focus on robotic-assisted and minimally invasive urologic surgery, genitourinary oncology, prostate cancer management and surgical innovation, with active engagement in multi-institutional and international collaborations. He has published extensively, with 56 Scopus-indexed documents, 463 citations and an h-index of 12, contributing to high-impact journals such as Frontiers in Oncology and the British Journal of Urology International and authoring expert consensuses on robotic-assisted radical prostatectomy. Prof. Di Gu is a recognized leader in medical education and mentorship, supervising national-level student projects and winning numerous teaching awards, including the Young Teachers’ English Teaching Elite Award and Guangdong Top Ten Young Medical Elites recognition. His research skills include advanced robotic surgical techniques, laparoscopic procedures, clinical trial design, translational oncology and medical education innovation. His honors reflect both academic and social impact, including Outstanding Teacher of Nanyue, China’s Most Beautiful Public Welfare Physician and top prizes in national and provincial teaching competitions. In conclusion, Prof. Di Gu exemplifies excellence in clinical practice, research innovation and education; his pioneering contributions to robotic urology and genitourinary oncology, combined with his leadership in professional societies and mentorship of the next generation, position him to continue advancing urologic medicine and making a global impact in patient care, research, and academic leadership.
Featured Publications
1. Chen, W., Wu, S., Li, G., Duan, X., Sun, X., Li, S., Zhao, Y., Gu, D., Zeng, G., & Liu, H. (2022). Accurate diagnosis of prostate cancer with CRISPR-based nucleic acid test strip by simultaneously identifying PCA3 and KLK3 genes. Biosensors and Bioelectronics
2. Chen, Z., Yang, R., Xu, Y., Liang, L., Ao, S., Wang, Z., Bai, P., Gu, D., Duan, X., Liu, Y., Zhong, W., Xu, P., Deng, T., Zeng, G., & Wang, C. (2022). PET imaging of bromodomain and extra-terminal domain inhibitors for the noninvasive assessment of metabolic changes in the liver and brain of early-stage alcoholic liver disease. Molecular Pharmaceutics.
3. Liu, Z., Guan, Z., Lan, H., Zhao, Y., Ye, Z., Lv, D.-J., Yu, Q., Wang, M., Peng, K., Fu, N., Mazzon, G., & Gu, D. (2022). Evaluating the lower urinary tract syndrome with a telemedicine application: An exploration of the electronic audiovisual prostate symptom score. Frontiers in Surgery, 9, Article 889123.
4. Xie, D., Gu, D., Lei, M., Cai, C., Zhong, W., Qi, D., Wu, W., Zeng, G., & Liu, Y. (2022). The application of indocyanine green in guiding prostate cancer treatment. Asian Journal of Urology, 9(2), 105–113.
5. Ge, F., Huo, Z., Liu, Y., Du, X., Wang, R., Lin, W., Wang, R., Chen, J., Lu, Y., Wen, Y., Cao, H., Shang, S., Eftekhar, M., & Gu, D. (2022). Association between schizophrenia and prostate cancer risk: Results from a pool of cohort studies and Mendelian randomization analysis. Comprehensive Psychiatry, 114, 152300.